14 February 2022 in The EMBO Journal
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
8 October 2024 in bioRxiv
SKSander B. van der Kooij
+8
Vault RNAs (vtRNAs) are a family of four small non-coding RNAs (ncRNAs) that are ubiquitously expressed in many eukaryotes and that regulate multiple cellular pathways. Their expression is increased upon infection with various DNA and RNA viruses. This suggests they are either co-opted by the virus to aid replication or function as an antiviral restriction factor. However, their precise molecular function remains unclear. Here, we show that replication of picornaviruses, alphaviruses, and beta-coronaviruses broadly enhances vtRNA expression. We find that genetic loss of vtRNAs inhibits replication of Sindbis virus (SINV) and encephalomyocarditis virus (EMCV), independent of the antiviral type I interferon (IFN) response. A proteomic screen uncovered the vtRNA interactome and revealed that vtRNAs associate with RNA binding proteins ELAVL1 and hnRNP C in uninfected and infected cells. VtRNAs facilitate the translocation of ELAVL1 and hnRNP C from the nucleus to the cytoplasm in infected cells, an event that is required for efficient viral replication. Moreover, hnRNP C and ELAVL1 fail to associate with viral RNA in the cytosol of SINV-infected cells in the absence of vtRNAs. Together, our findings reveal a novel molecular mechanism by which vtRNAs exert proviral activity during the course of SINV and EMCV infection, which opens up new avenues for therapeutic targeting to fight infectious diseases.
28 October 2021 in bioRxiv
RNA editing by the enzyme Adenosine Deaminase Acting on RNA 1 (ADAR1) is an important mechanism by which cells avoid innate immune responses to some endogenous RNAs. In ADAR1-deficient cells, unedited self RNAs can form base-paired structures that resemble viral RNAs and inadvertently activate antiviral innate immune pathways that lead to the induction of type I interferon (IFN). Rare mutations in ADAR1 cause Aicardi-Goutières Syndrome (AGS), a severe childhood autoinflammatory syndrome that is characterized by chronic and excessive type I IFN production and developmental delay. Conversely, ADAR1 dysfunction and consequent type I IFN production helps restrict tumor growth and potentiates the activity of some chemotherapy drugs. Induction of type I IFN in ADAR1-deficient cells is thought to be due to triggering of the cytosolic RIG-I-like receptor (RLR), MDA5, by unedited self RNAs. Here, we show that another RLR, LGP2, also has an essential role. We demonstrate that ADAR1-deficient human cells fail to mount a type I IFN response in the absence of LGP2 and this involves the canonical function of LGP2 as an RNA sensor and facilitator of MDA5-dependent signaling. Further, we show that the sensitivity of tumor cells to ADAR1 loss requires the presence of LGP2. Finally, we find that type I IFN induction in tumor cells depleted of ADAR1 and treated with some chemotherapeutics is fully dependent on the expression of LGP2. These findings highlight a central role for LGP2 in self RNA sensing with important clinical implications for the treatment of AGS as well as for the potential application of ADAR1-directed anti-tumor therapy.
3 November 2026 in bioRxiv
Self-derived double-stranded RNA (self-dsRNA) acts as potent triggers of autoinflammation and damage-associated molecular patterns in cancer and infection. However, the upstream processes controlling self-dsRNA homeostasis remain unclear. We uncover a non-canonical role for human Dicer in driving cell-intrinsic immunity to self-dsRNAs that arise from editing or splicing defects, epigenetic deregulation or mitochondrial stress. Dicer loss abolishes type-I interferon induction, PKR activation, and OAS-RNase L activation in response to self – but not exogenous – dsRNA in multiple cell types, including a clinically-relevant hiPSC model of neuroinflammation. Dicer interacts with G3BP1 and LGP2 to regulate self-dsRNA availability and recognition, respectively, independently of miRNAs. As immunostimulatory self-dsRNAs fail to accumulate and activate dsRNA sensors in absence of Dicer, these findings position Dicer as a central regulator of self-dsRNA sensing. Summary figure: Self-derived dsRNAs are potent triggers of innate immune activation that accumulate due to cellular dysfunction, such as mitochondrial stress, epigenetic deregulation or editing and splicing defects. Dicer and G3BP1 are jointly required for the cytosolic accumulation of self-dsRNA, and the activation of downstream innate immune dsRNA sensors, including Dicer interactors LGP2 and PKR. Self-dsRNA driven inflammation occurs in diverse pathological contexts – including neurodegeneration, autoimmunity, and cancer – thus making Dicer and its interactors promising targets for therapeutic intervention. Created in BioRender. Ter haar, L. (2025) https://BioRender.com/40ztdl0